161 results
Page 5 of 9
6-K
EX-99.1
ie5s23kocwwnvjil1e
6 Nov 20
Current report (foreign)
10:06am
6-K
EX-99.1
n03wvwq8
15 Oct 20
Galapagos and Servier report topline results for ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in knee osteoarthritis patients
5:27pm
S-8
EX-4.1
c7pe0p7ry6 j0d873w
9 Oct 20
Registration of securities for employees
4:32pm
S-8
EX-99.1
vta rb82m0byxofa66cw
9 Oct 20
Registration of securities for employees
4:32pm
6-K
EX-99.1
7yfoet9
25 Sep 20
Jyseleca® (filgotinib) approved in Japan for rheumatoid arthritis
6:05am
6-K
EX-99.1
alzfhg3fl
11 Sep 20
Primary endpoint achieved with ziritaxestat in NOVESA trial in systemic sclerosis patients
6:05am
6-K
EX-99.1
h8ixvkl 1ua
19 Aug 20
Current report (foreign)
6:00am
6-K
EX-99.2
sg2dl
6 Aug 20
Galapagos reports solid H1 2020 progress
4:01pm
6-K
EX-99.2
2n6 m7dqzxcr54ye8
11 May 20
Current report (foreign)
4:05pm
6-K
v5uzn
29 Apr 20
Current report (foreign)
4:39pm
6-K
EX-99.1
axq8zg2jhy1dxkw5s
16 Apr 20
Galapagos and Ryvu announce research collaboration
6:05am
6-K
EX-99.3
zo62k6m8c6x
27 Mar 20
Publication of the annual report and invitation to the The annual report for the financial year 2019, including a review of figures and performance, is available online at
4:49pm
6-K
EX-99.2
f96 h6highijmk14
27 Mar 20
Publication of the annual report and invitation to the The annual report for the financial year 2019, including a review of figures and performance, is available online at
4:49pm
6-K
EX-99.10
5mzj56
27 Mar 20
Publication of the annual report and invitation to the The annual report for the financial year 2019, including a review of figures and performance, is available online at
4:49pm